Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adedamola Omogbehin"'
Autor:
Sandra M. Swain, Eshetu Tefera, P. Herbolsheimer, Adedamola Omogbehin, Mahsa Mohebtash, Raquel Nunes, Filipa Lynce, Antoinette F. Newman, Brandi N. Robinson, Mihriye Mete, Asma Dilawari, Pamela Randolph-Jackson, Yvonne Ottaviano, A Mohapatra, Paula R. Pohlmann, Christopher Gallagher
Publikováno v:
Cancer Research. 77:P3-10
Background: Increasing Black patients' participation in cancer clinical trials is important because of the population's lower survival rate. Accrual for Blacks is the lowest of all groups at 0.5-1.5%. Our study aims to increase trial participation ra
Autor:
Christopher Gallagher, Avani Mohapatra, P. Herbolsheimer, Antoinette F. Newman, Raquel Nunes, Eshetu Tefera, Brandi N. Robinson, Richard A. Brown, Young Lee, Asma Dilawari, Sandra M. Swain, Adedamola Omogbehin, Pamela Randolph-Jackson, Yvonne Ottaviano, Mahsa Mohebtash, Mihriye Mete, Filipa Lynce, Paula R. Pohlmann
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 3, Iss 1, Pp 1-7 (2017)
npj Breast Cancer, Vol 3, Iss 1, Pp 1-7 (2017)
There is a striking racial and ethnic disparity in incidence and mortality of cancer yet minorities remain markedly underrepresented in clinical trials. This pilot study set out to determine the impact of a 15-min culturally tailored educational vide
Autor:
Sana D. Karam, K. William Harter, Rosanna Chen, Ann K. Jay, Abdul Rashid, Edward F Aulisi, Margaux Wooster, Adedamola Omogbehin, Jeff Jacobson, Alexander X. Tai, Pamela Randolph-Jackson, Nimrah A. Baig
Publikováno v:
Journal of Radiation Oncology
Objective Effective short-term outcomes have been well documented for trigeminal neuralgia (TN) patients treated with Gamma Knife radiosurgery (GKRS) with reported success rates of 70–90 % with median follow-up intervals of 19–75 months. Fewer se
Publikováno v:
Journal of the National Medical Association. 94(8)
More than two-thirds of the patients with osseous metastases experience debilitating bone pain, requiring some form of pain relief. Analgesics are limited in their efficacy. Palliative application of hemi-body external beam radiation therapy in the t